GE Healthcare and Varian, Inc. Announce Pre-Clinical Magnetic Resonance Imaging (MRI) System
Posted on: Tuesday, 12 May 2009, 16:00 CDT
The Discovery MR901 combines GE Healthcare's state-of-the-art diagnostic technology with Varian's leading scientific platform to provide a pre-clinical MRI system for the scientific community. The pre-clinical technology aims to excel in soft tissue contrast and non-invasive techniques, including those used in research for anatomy, metabolism, and physiology in research models.
"Our offering provides a new level of depth and versatility to the scientific community," said
The range of preclinical MRI applications includes brain and organ imaging, tumor assessment, disease progression and functional imaging. Other potential research applications include investigation of new contrast mechanisms and agents, monitoring gene expression, analysis of protein interactions, and determination of pharmacokinetics.
Varian and GE Healthcare announced the Discovery MR901 at the International Society for Magnetic Resonance in Medicine (ISMRM) conference in
"I am very pleased with how the system integration has progressed. The first system is expected to ship this summer, adding to our installed-base of leading MRI and NMR instrumentation," said
For more technical information about Varian products, please visit http://www.varianinc.com/products/
About Varian, Inc.:
Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,700 people worldwide and operates manufacturing facilities in
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre- symptomatic disease detection and disease prevention. Headquartered in the
SOURCE Varian, Inc.; GE Healthcare
Source: PR Newswire
Related Articles
- US Oncology Provides Full Service Management of Clinical Trials
- BNY ConvergEx Group's BNY Jaywalk Announces Independent Research Provider Performance Award Program
- Brendan Light of BuzzBack Market Research to Host Product Naming Internet Webinar on Dec. 4th
- InTouch Health Partners With Neurostar to Add Clinical Image Management Services to Telestroke Offering
- BMO Capital Markets Continues to Expand Its U.S. Healthcare Equity Research Group
- SK&A Expands Healthcare Information Research Center
- CVS Corporation Completes Acquisition of MinuteClinic, Largest Provider of Retail-Based Health Clinics in the U.S.
- CVS Corporation to Acquire MinuteClinic, Largest Provider of Retail-Based Health Clinics in the US
- Stop Rising Healthcare Costs Using Toyota Lean Production Methods
- Wipro Technologies Forges Strategic Alliance With FullTilt Solutions To Provide Enterprise Product Information Management (PIM) To Consulting Clients
 |
 |
User Comments (0)
RSS Feeds